2013, Number 2
Determinating the location of the permanent pacemaker lead in the right ventricle outflow tract by computed tomography
Language: Spanish
References: 12
Page: 69-75
PDF size: 352.27 Kb.
ABSTRACT
Introduction: Determination of the location of the lead of the permanent pacemaker in the right ventricle outflow tract (RVOT) it’s difficult with the conventional techniques (fluoroscopic images and electrocardiography). The computed tomography (CT) allows to determinate in three dimensions the relation between the lead and the RVOT. Objective: Determine the location of the electrode lead by computed tomography and compare the results with electrocardiographic and fluoroscopy images localization. Material and methods: 36 patients were included with VVI permanent pacemaker with the lead in the RVOT. A 12-lead electrocardiogram, fluoroscopy images and CT were performed to determine the position of the lead in the RVOT. Results: By electrocardiogram, we located the lead in septal wall 58.3% and free wall 41.7%. By fluoroscopy images in left anterior oblique (LAO) 35° the lead was located on the anterior wall 5.6%, free wall 38.9% and septal 55.6%; in LAO 45° anterior wall 2.8%, free wall 44.4% and septal 52.8%. By Tomography the lead was positioned on anterior wall in 39%, free wall 48% and septal 13%. The Kappa coefficient of the 3 tests showed very low concordance. Conclusion: CT is a better method for determining the position of the lead on the RVOT compared to fluoroscopy images an electrocardiogram.REFERENCES
Vardas P, Auricchio A, Blanc JJ, Daubert JC, Drexler H, Ector H et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. European Heart Journal. 2007; 28: 2256-2295.
Sweeney MO, Hellkamp AS, Ellenbogen KA, Greenspon AJ, Freedman RA, Lee KL et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation. 2003; 107: 2932-7.